The current valuation score of Cellectar Biosciences Inc is 8.85, ranking 41 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is -0.48, which is -133.21% below the recent high of 0.16 and -67.25% above the recent low of -0.80.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.